Value of Intensity-Modulated Radiotherapy in Stage IV Head-and-Neck Squamous Cell Carcinoma
- 1 December 2010
- journal article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 78 (5) , 1373-1380
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patientsRadiotherapy and Oncology, 2009
- Impact of Adding Concomitant Chemotherapy to Hyperfractionated Accelerated Radiotherapy for Advanced Head-and-Neck Squamous Cell CarcinomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG AnalysisJournal of Clinical Oncology, 2008
- Head and neck cancerThe Lancet, 2008
- Evidence behind use of intensity-modulated radiotherapy: a systematic review of comparative clinical studiesThe Lancet Oncology, 2008
- Early experience with a hybrid accelerated radiotherapy schedule for locally advanced head and neck cancerHead & Neck, 2007
- Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysisThe Lancet, 2006
- A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neckBMC Cancer, 2006
- Toxicity in head and neck cancer: a review of trends and issuesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2000
- Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual dataThe Lancet, 2000